Mavens Biotech Ltd. - Research Center
590083 MAVENSBIO Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 16 | Mar ' 16 | Sep ' 15 | Sep ' 14 | Sep ' 13 | |
|---|---|---|---|---|---|
| Sales | 0.56 | 0.41 | 0.42 | 0.43 | 21.66 |
| Operating profit | 0.07 | 0.13 | 0.14 | 0.11 | 0.29 |
| Interest | - | - | - | - | - |
| Gross profit | 0.07 | 0.13 | 0.14 | 0.16 | 0.34 |
| EPS (Rs) | - | 0.01 | 0.01 | 0.01 | 0.02 |
Half yearly
results in details
| Sep ' 16 | Mar ' 16 | Sep ' 15 | Sep ' 14 | Sep ' 13 | |
|---|---|---|---|---|---|
| Other income | - | - | - | 0.05 | 0.05 |
| Stock adjustment | 0.22 | - | - | - | 0.04 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.11 | 0.11 | 0.11 | 0.12 | 0.11 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | 0.08 | - | - | - |
| Other expenses | 0.16 | 0.09 | 0.17 | 0.20 | 21.22 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.05 | 0.07 | 0.07 | 0.09 | 0.11 |
| Taxation | - | - | - | - | - |
| Net profit / loss | 0.02 | 0.06 | 0.06 | 0.07 | 0.23 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | 747.00 | 747.00 | 747.00 |
| Agg.of non promotoholding (%) | - | - | 67.96 | 67.96 | 67.96 |
| OPM (%) | 12.42 | 32.37 | 32.72 | 25.05 | 1.33 |
| GPM (%) | - | - | - | 33.33 | 1.57 |
| NPM (%) | - | - | - | 15.43 | 1.07 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis